| Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study SA Guler, L Ebner, C Aubry-Beigelman, PO Bridevaux, M Brutsche, ... European respiratory journal 57 (4), 2021 | 421 | 2021 |
| Progression of fibrosing interstitial lung disease AW Wong, CJ Ryerson, SA Guler Respiratory research 21 (1), 32, 2020 | 138 | 2020 |
| Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a … AW Popp, S Guler, O Lamy, C Senn, H Buffat, R Perrelet, D Hans, ... Journal of bone and mineral research 28 (3), 449-454, 2013 | 119 | 2013 |
| YouTube videos as a source of misinformation on idiopathic pulmonary fibrosis GC Goobie, SA Guler, KA Johannson, JH Fisher, CJ Ryerson Annals of the American Thoracic Society 16 (5), 572-579, 2019 | 93 | 2019 |
| Heterogeneity in unclassifiable interstitial lung disease. A systematic review and meta-analysis SA Guler, K Ellison, M Algamdi, HR Collard, CJ Ryerson Annals of the American Thoracic Society 15 (7), 854-863, 2018 | 88 | 2018 |
| Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities P Spagnolo, CJ Ryerson, R Putman, J Oldham, M Salisbury, N Sverzellati, ... The Lancet Respiratory Medicine 9 (9), 1065-1076, 2021 | 76 | 2021 |
| Does systemic sclerosis–associated interstitial lung disease burn out? Specific phenotypes of disease progression SA Guler, TA Winstone, D Murphy, C Hague, J Soon, N Sulaiman, KH Li, ... Annals of the American Thoracic Society 15 (12), 1427-1433, 2018 | 74 | 2018 |
| Body mass index and complications following major gastrointestinal surgery: a prospective, international cohort study and meta‐analysis EuroSurg Collaborative, R Blanco‐Colino, S Lee, SK Kamarajah, P Vasko, ... Colorectal Disease 20 (8), O215-O225, 2018 | 56 | 2018 |
| Frailty is common and strongly associated with dyspnoea severity in fibrotic interstitial lung disease KM Milne, JM Kwan, S Guler, TA Winstone, A Le, N Khalil, PG Camp, ... Respirology 22 (4), 728-734, 2017 | 53 | 2017 |
| Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes SA Guler, JM Kwan, JM Leung, N Khalil, PG Wilcox, CJ Ryerson European Respiratory Journal 55 (1), 2020 | 42 | 2020 |
| Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study SA Guler, SA Hur, SA Lear, PG Camp, CJ Ryerson Respiratory research 20, 1-9, 2019 | 42 | 2019 |
| Severity and features of frailty in systemic sclerosis-associated interstitial lung disease SA Guler, JM Kwan, TA Winstone, KM Milne, JV Dunne, PG Wilcox, ... Respiratory medicine 129, 1-7, 2017 | 31 | 2017 |
| Incidence and prognostic significance of hypoxemia in fibrotic interstitial lung disease: an international cohort study YH Khor, L Gutman, NA Hussein, KA Johannson, IN Glaspole, SA Guler, ... Chest 160 (3), 994-1005, 2021 | 28 | 2021 |
| Minimal important difference for physical activity and validity of the international physical activity questionnaire in interstitial lung disease SA Hur, SA Guler, N Khalil, PG Camp, JA Guenette, JJ Swigris, ... Annals of the American Thoracic Society 16 (1), 107-115, 2019 | 28 | 2019 |
| Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study SA Guler, S Am Hur, MK Stickland, P Brun, L Bovet, AE Holland, ... Thorax 77 (6), 589-595, 2022 | 26 | 2022 |
| Azithromycin for the treatment of chronic cough in idiopathic pulmonary fibrosis: a randomized controlled crossover trial SA Guler, C Clarenbach, M Brutsche, K Hostettler, AK Brill, A Schertel, ... Annals of the American Thoracic Society 18 (12), 2018-2026, 2021 | 24 | 2021 |
| Interstitial lung disease in 2020: a history of progress SA Guler, TJ Corte Clinics in chest medicine 42 (2), 229-239, 2021 | 23 | 2021 |
| Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts C Machahua, SA Guler, MP Horn, L Planas-Cerezales, ... BMJ open respiratory research 8 (1), e000827, 2021 | 23 | 2021 |
| Costs of workplace productivity loss in patients with fibrotic interstitial lung disease M Algamdi, M Sadatsafavi, JH Fisher, J Morisset, KA Johannson, CD Fell, ... Chest 156 (5), 887-895, 2019 | 21 | 2019 |
| Unclassifiable interstitial lung disease: from phenotyping to possible treatments SA Guler, CJ Ryerson Current opinion in pulmonary medicine 24 (5), 461-468, 2018 | 20 | 2018 |
